Dynamic association of tau with neuronal membranes is regulated by phosphorylation

Neurobiology of Aging

Volumn 33, Issue 2, 2012, Pages 431.e27-431.e38

  Pooler, Amy M ^a   Usardi, Alessia ^a   Evans, Catherine J ^a   Philpott, Karen L ^b   Noble, Wendy ^a   Hanger, Diane P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Casein kinase 1; Fyn; Glycogen synthase kinase 3; Phosphorylation; Plasma membrane; Tau

Indexed keywords

CASEIN KINASE I; GLYCOGEN SYNTHASE KINASE 3; PROTEIN AT8; PROTEIN KINASE FYN; PROTEIN SH3; TAU PROTEIN; TAU PROTEIN 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; MOUSE; MUTATIONAL ANALYSIS; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM;

EID: 82755189704     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.01.005     Document Type: Article

References (46)

1. Arrasate M., Perez M., Avila J. Tau dephosphorylation at tau-1 site correlates with its association to cell membrane. Neurochem. Res. 2000, 25:43-50.
2. Baba A., Akagi K., Takayanagi M., Flanagan J.G., Kobayashi T., Hattori M. Fyn tyrosine kinase regulates the surface expression of glycosylphosphatidylinositol-linked ephrin via the modulation of sphingomyelin metabolism. J. Biol. Chem. 2009, 284:9206-9214.
3. Bhaskar K., Yen S.H., Lee G. Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem. 2005, 280:35119-35125.
4. Brandt R., Leger J., Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 1995, 131:1327-1340.
5. Buxbaum J.D., Gandy S.E., Cicchetti P., Ehrlich M.E., Czernik A.J., Fracasso R.P., Ramabhadran T.V., Unterbeck A.J., Greengard P. Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6003-6006.
6. Cardona-Gómez G.P., Arango-Davila C., Gallego-Gómez J.C., Barrera-Ocampo A., Pimienta H., Garcia-Segura L.M. Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit in postischemic hippocampus. Neuroreport 2006, 17(12):1337-1341.
7. Cuchillo-Ibanez I., Seereeram A., Byers H.L., Leung K.Y., Ward M.A., Anderton B.H., Hanger D.P. Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J. 2008, 22:3186-3195.
8. Eidenmuller J., Fath T., Maas T., Pool M., Sontag E., Brandt R. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein. Biochem. J. 2001, 357:759-767.
9. Ekinci F.J., Shea T.B. Phosphorylation of tau alters its association with the plasma membrane. Cell. Mol. Neurobiol. 2000, 20:497-508.
10. Farah C.A., Perreault S., Liazoghli D., Desjardins M., Anton A., Lauzon M., Paiement J., Leclerc N. Tau interacts with Golgi membranes and mediates their association with microtubules. Cell Motil. Cytoskeleton 2006, 63:710-724.
11. Flajolet M., He G., Heiman M., Lin A., Nairn A.C., Greengard P. Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4159-4164.
12. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4051-4055.
13. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
14. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 1992, 147:58-62.
15. Hanger D.P., Byers H.L., Wray S., Leung K.Y., Saxton M.J., Seereeram A., Reynolds C.H., Ward M.A., Anderton B.H. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 2007, 282:23645-23654.
16. Ho G.J., Hashimoto M., Adame A., Izu M., Alford M.F., Thal L.J., Hansen L.A., Masliah E. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol. Aging 2005, 26:625-635.
17. Hoe H.S., Minami S.S., Makarova A., Lee J., Hyman B.T., Matsuoka Y., Rebeck G.W. Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing. J. Biol. Chem. 2008, 283:6288-6299.
18. Illenberger S., Zheng-Fischhofer Q., Preuss U., Stamer K., Baumann K., Trinczek B., Biernat J., Godemann R., Mandelkow E.M., Mandelkow E. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell 1998, 9:1495-1512.
19. Iqbal K., Liu F., Gong C.X., Alonso-Adel C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 2009, 118:53-69.
20. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wolfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Gotz J. Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse Models. Cell 2010, 142:387-397.
21. Johnson G.V., Stoothoff W.H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 2004, 117:5721-5729.
22. Kawarabayashi T., Shoji M., Younkin L.H., Wen-Lang L., Dickson D.W., Murakami T., Matsubara E., Abe K., Ashe K.H., Younkin S.G. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 2004, 24:3801-3809.
23. Klein C., Kramer E.M., Cardine A.M., Schraven B., Brandt R., Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J. Neurosci. 2002, 22:698-707.
24. Lee G. Tau and src family tyrosine kinases. Biochim. Biophys. Acta 2005, 1739:323-330.
25. Lee G., Newman S.T., Gard D.L., Band H., Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 1998, 111:3167-3177.
26. Lee G., Thangavel R., Sharma V.M., Litersky J.M., Bhaskar K., Fang S.M., Do L.H., Andreadis A., Van Hoesen G., Ksiezak-Reding H. Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 2004, 24:2304-2312.
27. Leger J., Kempf M., Lee G., Brandt R. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J. Biol. Chem. 1997, 272:8441-8446.
28. Li G., Yin H., Kuret J. Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J. Biol. Chem. 2004, 279:15938-15945.
29. Maas T., Eidenmuller J., Brandt R. Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J. Biol. Chem. 2000, 275:15733-15740.
30. Mandelkow E.M., Drewes G., Biernat J., Gustke N., Van Lint J., Vandenheede J.R., Mandelkow E. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 1992, 314:315-321.
31. Martin S., Bouschet T., Jenkins E.L., Nishimune A., Henley J.M. Bidirectional regulation of kainate receptor surface expression in hippocampal neurons. J. Biol. Chem. 2008, 283:36435-36440.
32. Martzen M.R., Nagy A., Coleman P.D., Zwiers H. Altered phosphorylation of growth-associated protein B50/GAP-43 in Alzheimer disease with high neurofibrillary tangle density. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11187-11191.
33. Mashhoon N., DeMaggio A.J., Tereshko V., Bergmeier S.C., Egli M., Hoekstra M.F., Kuret J. Crystal structure of a conformation-selective casein kinase-1 inhibitor. J. Biol. Chem. 2000, 275:20052-20060.
34. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W., Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001, 56:127-129.
35. Paudel H.K., Lew J., Ali Z., Wang J.H. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 1993, 268:23512-23518.
36. Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
37. Pooler A.M., Hanger D.P. Functional implications of the association of tau with the plasma membrane. Biochem. Soc. Trans. 2010, 38:1012-1015.
38. Reynolds C.H., Garwood C.J., Wray S., Price C., Kellie S., Perera T., Zvelebil M., Yang A., Sheppard P.W., Varndell I.M., Hanger D.P., Anderton B.H. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J. Biol. Chem. 2008, 283:18177-18186.
39. Shenoy-Scaria A.M., Dietzen D.J., Kwong J., Link D.C., Lublin D.M. Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J. Cell Biol. 1994, 126:353-363.
40. Smith M.J., Crowther R.A., Goedert M. The natural osmolyte trimethylamine N-oxide (TMAO) restores the ability of mutant tau to promote microtubule assembly. FEBS Lett. 2000, 484:265-270.
41. Tanimukai H., Grundke-Iqbal I., Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 2005, 166:1761-1771.
42. Uemura K., Kuzuya A., Shimozono Y., Aoyagi N., Ando K., Shimohama S., Kinoshita A. GSK3beta activity modifies the localization and function of presenilin 1. J. Biol. Chem. 2007, 282:15823-15832.
43. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 2001, 168:402-412.
44. Walter J., Fluhrer R., Hartung B., Willem M., Kaether C., Capell A., Lammich S., Multhaup G., Haass C. Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 2001, 276:14634-14641.
45. Williamson R., Usardi A., Hanger D.P., Anderton B.H. Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J. 2008, 22:1552-1559.
46. Wolven A., Okamura H., Rosenblatt Y., Resh M.D. Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol. Biol. Cell 1997, 8:1159-1173.